A carregar...
Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with an overall median 5-year survival rate of 8%. This poor prognosis is because of the development of resistance to chemotherapy and radiation therapy and lack of effective targeted therapies. IκB kinase enhancer (IKBKE) overexpression wa...
Na minha lista:
| Publicado no: | Transl Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Neoplasia Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6994835/ https://ncbi.nlm.nih.gov/pubmed/32004866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.11.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|